Written questions and answers

Written questions allow Members of Parliament to ask government ministers for information on the work, policy and activities of government departments.

Historical written answers can be found in Hansard.

Find the latest written questions and answers for the 2019 session below. We welcome your feedback on this service.

Show
by:
Find by:
Close

UIN

Unique Identifying Number – Every written question in the House of Commons has a UIN per Parliament. In the House of Lords each written questions has a UIN per parliamentary session.
Showing 1-20 out of 67
Results per page
Results per page 20 | 50 | 100
Expand all answers
Print selected
Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 19 December 2019
Department for Digital, Culture, Media and Sport
Charities: Lotteries
Commons
To ask the Secretary of State for Digital, Culture, Media and Sport, what steps the Government is taking to raise the maximum amount that can be raised each year by an individual charity lottery from £10 million; and if she will make a statement.
A
Answered by: Helen Whately
Answered on: 07 January 2020

New limits to the per draw sales, annual sales and maximum prize for society lotteries were announced on 16 July 2019. Affirmative secondary legislation is required to change the limits, and the Gambling Commission is also required to consult on changes to its Licence Conditions and Codes of Practice (LCCP).

I hope to lay the draft Order in Parliament in January 2020, and the changes to come into force during 2020. The Order will include transitional arrangements for the first year, to enable operators to take advantage of the new limits as soon as possible.

The Gambling Commission has already launched its consultation in anticipation of the legislation, and this will help ensure the new limits can come into force as swiftly as possible. Their consultation also covers measures to improve transparency of society lotteries and will run until 12 March 2020.

I shall not be making any further statement at this time.

Grouped Questions: 76 | 77
Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 19 December 2019
Attorney General
David Duckenfield
Commons
To ask the Attorney General, what estimate he has made of the cost to the public purse of the (a) first, (b) second and (c) third prosecution against Mr David Duckenfield on manslaughter in relation to the Hillsborough tragedy; and if he will make a statement.
A
Answered by: Michael Ellis
Answered on: 07 January 2020

This was a complex and harrowing case. Every effort was made to build a robust case for prosecution, in accordance with the Code for Crown Prosecutors and the case was handled by a team of experienced specialist prosecutors.

As it involved the prosecution of more than one defendant, it is not possible to state definitively the total costs in relation to the prosecution of David Duckenfield alone. In June 2017, David Duckenfield, the police commander in charge of safety during the Hillsborough stadium disaster, was charged with gross negligence manslaughter. At trial in April 2019, the jury was unable to reach a verdict against David Duckenfield, while a second defendant, Graham Mackrell, was convicted of a health and safety offence. In November 2019, after a retrial at Preston Crown Court, the jury found David Duckenfield not guilty.

The CPS estimates the cost of legal counsel fees and other prosecution costs for the prosecution of both David Duckenfield and Graham Mackrell to be approximately £1.97 million. CPS records do not capture the cost of the time spent by internal CPS staff on this case.

The CPS cannot comment on costs incurred by the police, HM Courts and Tribunals, or any other partners in this case. Nor can the CPS comment on the private prosecution referred to in the question, which was brought against David Duckenfield by the Hillsborough Family Support Group in 2000.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 19 December 2019
Ministry of Justice
Miscarriages of Justice: Compensation
Commons
To ask the Secretary of State for Justice, on what date the Miscarriage of Justice Service received the application from Mr David Bryant of Christchurch for compensation; what the timeframe is for a decision to be made on that application; and if he will make a statement.
A
Answered by: Wendy Morton
Answered on: 07 January 2020

The Miscarriage of Justice Application Service (‘MOJAS’) received Mr Bryant’s application on 8 March 2018.

Each application is necessarily fact specific and enquiries need to be undertaken so that the Secretary of State has all the required information before making a decision. This involves, amongst other matters, contacting external agencies (such as the Crown Court, Court of Appeal or Crown Prosecution Service) to confirm the facts for each application and obtain documentation such as judgments and court files.

Over the past weeks, MOJAS have been carefully reviewing all the requisite material in Mr Bryant’s case in line with the requirements of section 133 of the Criminal Justice Act 1988. We remain hopeful of reaching a decision within the next three months.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 19 December 2019
Ministry of Justice
Television: Licensing
Commons
To ask the Secretary of State for Justice, how many prosecutions for television licence fee evasion were made by magistrates' courts in (a) Dorset and (b) England in the last 12 months for which information is available; and if he will make a statement.
A
Answered by: Chris Philp
Answered on: 07 January 2020

The Ministry of Justice has published information on prosecutions and court outcomes by police force area, which can be found in the Court Outcome by Police Force Area data tool available here:

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/804509/court-outcomes-by-PFA-2018.xlsx

In the data tool:

  • Use the ‘Court type’ filter and select ’02: Magistrates court’.

  • Use the ‘Offence’ filter to select ‘191A Television licence evasion’.

  • Under the ‘Row Labels’ filter deselect ‘Dyfed-Powys, Gwent, North Wales and South Wales’ to include on the results for England. The number of prosecutions in a) each police force area, and b) the combined total across all areas, will then be visable by year.

    Following the introduction of Single Justice Procedure (SJP) offences in the Criminal Justice and Courts Act 2015, adults tried for summary non-imprisonable offences at the magistrates’ court can be dealt with remotely (the defendant does not need to physically attend court). Caution should be taken when interpreting trends by Police force area as particular courts may be allocated all the SJP offences for the entire region.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 19 December 2019
Treasury
Public Sector: Redundancy Pay
Commons
To ask the Chancellor of the Exchequer, when the £95,000 cap on public sector exit payments is planned to come into force; what the timeframe is for the publication of the Government response to the consultation on the draft regulations that closed on 3 July 2019; and if he will make a statement.
A
Answered by: Rishi Sunak
Answered on: 07 January 2020

The government is currently considering responses to the consultation and will publish its response in due course. Once the government response has been published, regulations are required to be laid before Parliament for approval through the affirmative procedure to bring the cap into force.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 20 December 2019
Treasury
Motorhomes: Excise Duties
Commons
To ask the Chancellor of the Exchequer, if he will make it his policy to classify motorhomes as commercial vehicles for taxation purposes; and if he will make a statement.
A
Answered by: Mr Simon Clarke
Answered on: 07 January 2020

The Government reformed Vehicle Excise Duty (VED) to encourage the uptake of vehicles with lower CO2 emissions to help us meet our legally binding climate change targets. It is right that under the reformed system motorhomes with high CO2 emissions pay greater first year VED than those with lower emissions.

I met representatives of the industry to discuss the matter and I understand their concerns. As with all taxes, the Government keeps the VED treatment of motorhomes under review.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 20 December 2019
Ministry of Housing, Communities and Local Government
Mobile Homes
Commons
To ask the Secretary of State for Housing, Communities and Local Government, what steps his Department is taking to prevent park homes from being advertised as bungalows in promotional marketing; and if he will make it his policy to raise awareness of the legal difference between a home which is a real estate in land and chattel or personal property.
A
Answered by: Esther McVey
Answered on: 07 January 2020

The Government is committed to improving the park homes sector and ensuring that residents are better protected.

Consumer Rights legislation is already in place to protect consumers from unfair or misleading trading practices and ban misleading omissions and aggressive sales tactics.

We have published a factsheet (https://www.gov.uk/government/publications/buying-a-park-home) for anyone intending to buy a park home. There is also valuable information for those buying a home in the Government’s How to Buy a Home Guide (https://www.gov.uk/government/publications/how-to-buy-a-home). In addition, free independent advice has been made available through the Leasehold Advisory Service.

We have set up a working group to examine how messages about residents’ rights and responsibilities can be improved and better disseminated. The working group will publish its recommendations in due course.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 20 December 2019
Ministry of Housing, Communities and Local Government
Right to Buy Scheme: Housing Associations
Commons
To ask the Secretary of State for Housing, Communities and Local Government, what steps he is taking to enable tenants of Housing Associations in England to have a Right to Buy; and if he will make a statement.
A
Answered by: Esther McVey
Answered on: 07 January 2020

The Voluntary Right to Buy for housing association tenants is currently being piloted in the Midlands, which is giving thousands of tenants in the East and West Midlands the opportunity to enjoy the benefits of home ownership. The demand for the pilot was high. Over 9,000 households registered for the ballot in August 2018, with 6,000 tenants being given the opportunity to apply to their housing association. The pilot will be fully evaluated after its completion.

As set out in the 2019 manifesto, we will be evaluating new pilot areas. We will announce more details on this in due course.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 20 December 2019
Cabinet Office
Fixed-term Parliaments Act 2011
Commons
To ask the Chancellor of the Duchy of Lancaster and Minister for the Cabinet Office, whether he plans to bring forward legislative proposals to repeal the Fixed Term Parliaments Act 2011; what assessment he has made of the effect of repealing that Act on the Royal Prerogative power of the Monarch to dissolve the UK Parliament; and if he will make a statement.
A
Answered by: Chloe Smith
Answered on: 07 January 2020

As set out in the Queen's Speech, the Government will repeal the Fixed Term Parliaments Act. Prior to the Fixed Term Parliaments Act, an election was called through the use of the Royal Prerogative powers of the Monarch on the advice of the Prime Minister.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 10 July 2019
Department for Work and Pensions
Personal Independence Payment
Commons
To ask the Secretary of State for Work and Pensions, when his Department plans to implement the Order made by Judge Ashley in the Poole First Tier Tribunal on 28 May 2019, reference SC238/18/01260, on the awarding of personal independence payment with effect from 17 October 2018 to the person with National Insurance Number YY146593D.
A
Answered by: Justin Tomlinson
Answered on: 15 July 2019

The decision made by the First Tier Tribunal on 28 May 2019 was implemented for the claimant on 9 July 2019.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 10 July 2019
Department of Health and Social Care
Spinal Muscular Atrophy: Nusinersen
Commons
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 8 July 2019 to Question 369611 on Spinal Muscular Atrophy (SMA), what the evidential basis is that Spinraza does not work effectively on people with SMA that are excluded from access to that drug following the announcement of 15 May 2019 by NICE on that drug; and if he will make a statement.
A
Answered by: Seema Kennedy
Answered on: 15 July 2019

The National Institute for Health and Care Excellence (NICE) is currently developing recommendations for the National Health Service on the use of Spinraza for the treatment of spinal muscular atrophy (SMA) through its technology appraisal programme. NICE recommends technologies for use in the NHS when the evidence demonstrates that they are clinically effective and represent a cost-effective use of NHS resources.

There are several subtypes of SMA and, in the case of Spinraza, NICE has advised that it was not presented with evidence in SMA type 0 and SMA type 4. Evidence presented for the SMA type 3 population, who had lost the ability to walk, was limited and immature and resulted in its independent Appraisal Committee concluding that the size and nature of the benefits of Spinraza for this population were uncertain. Therefore, they were not included in the managed access arrangement (MAA) agreed by NHS England and Biogen.

Following publication of the initial MAA, the company presented further clinical evidence and the MAA was extended to include paediatric patients, who have recently (in the previous 12 months) lost the ability to walk independently.

Uniquely for this type of arrangement, during the five-year course of the MAA, should evidence become available on the potential benefits of Spinraza for type 3 SMA patients that are currently not included in the MAA, NICE will review that evidence to see whether it would support a change in the MAA inclusion criteria.

Q
(Christchurch)
Asked on: 03 July 2019
Prime Minister
Members: Correspondence
Commons
To ask the Prime Minister, pursuant to the Answer on 21 May 2019 to Question 255260, whether she plans to reply to the letter from the hon. Member for Christchurch, dated 18 February 2019 before the Summer recess.
A
Answered by: Mrs Theresa May
Answered on: 12 July 2019
A reply has been sent.
Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 03 July 2019
Department of Health and Social Care
Spinal Muscular Atrophy: Drugs
Commons
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 1 July 2019 to Question 269609 on Spinal Muscular Atrophy, if he will place in the Library a copy of the managed access agreement.
A
Answered by: Seema Kennedy
Answered on: 08 July 2019

The Managed Access Agreement for nusinersen for the treatment of spinal muscular atrophy which has been approved by NHS England, Biogen, the National Institute for Health and Care Excellence, the three main patient groups (Muscular Dystrophy UK, Spinal Muscular Atrophy UK, Treat SMA) and clinicians can be found at the following link:

https://www.nice.org.uk/guidance/gid-ta10281/documents/committee-papers-2

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 03 July 2019
Department of Health and Social Care
Spinal Muscular Atrophy: Drugs
Commons
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 1 July 2019 to Question 269610 on Spinal Muscular Atrophy: Drugs, what the maximum length of time is for the period of further data collection.
A
Answered by: Seema Kennedy
Answered on: 08 July 2019

The Managed Access Agreement (MAA) for nusinersen for treating spinal muscular atrophy states that the data collection will be in place for a minimum of three years and up to the automatic expiry of the MAA on the fifth anniversary, unless the MAA expires earlier as a result of the publication of the National Institute for Health and Care Excellence’s reappraisal of nusinersen.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 03 July 2019
Department of Health and Social Care
Spinal Muscular Atrophy: Drugs
Commons
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 1 July 2019 to Question 369611 on Spinal Muscular Atrophy: Drugs, what estimate he has made of the number of patients affected by the NICE announcement of 15 May 2019.
A
Answered by: Seema Kennedy
Answered on: 08 July 2019

NHS England and NHS Improvement have estimated that circa 630 patients will access nusinersen over a period of five years, which is the maximum period of the Managed Access Agreement.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 26 June 2019
Ministry of Justice
Probate
Commons
To ask the Secretary of State for Justice, what information he holds on when probate will be granted in the case of Carol Rosalind Green who died on 24 September 2018; and if he will make an assessment of the effect the time taken to grant probate on the ability of the executors to complete the sale of the deceased person's property.
A
Answered by: Robert Buckland
Answered on: 01 July 2019

We are unable to locate the case without further details. If my Hon. Friend writes to me with details of the case, I will ask my officials to look into the matter.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 26 June 2019
Department of Health and Social Care
Spinal Muscular Atrophy: Drugs
Commons
To ask the Secretary of State for Health and Social Care, what estimate he has made of the annual cost to the public purse of (a) the decision by NICE in May 2019 to enable people with spinal muscular atrophy to access new drugs and (b) enabling all people with relevant conditions to access those drugs; and if he will make a statement.
A
Answered by: Seema Kennedy
Answered on: 01 July 2019

The National Institute for Health and Care Excellence has advised that the total budget impact for the National Health Service at list prices to make nusinersen available for the total population with spinal muscular atrophy has been projected to be £156 million. The actual budget impact is subject to a managed access agreement and a confidential commercial agreement between NHS England and NHS Improvement and the company.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 26 June 2019
Department of Health and Social Care
Spinal Muscular Atrophy: Drugs
Commons
To ask the Secretary of State for Health and Social Care, how many and what proportion of people with spinal muscular atrophy will be eligible for access to NHS drugs for treatment following the 15 May 2019 announcement by NICE; what his policy is on people who have been excluded from that access; and if he will make a statement.
A
Answered by: Seema Kennedy
Answered on: 01 July 2019

NHS England, NHS Improvement, the National Institute for Health and Care Excellence (NICE) and Biogen have worked together extensively to reach an arrangement that allows access to nusinersen for most people with spinal muscular atrophy types 1, 2 and 3 along with pre-symptomatic patients.

NICE has advised that because of the difficulties in being confident about the clinical evidence and the cost-effectiveness of nusinersen, it was necessary to agree access criteria for a period of further data collection to try and better understand how nusinersen affects people with spinal muscular atrophy. Therefore a managed access agreement has been reached, which should not only help answer these questions but also address the financial risk and challenges for implementation in the National Health Service.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 26 June 2019
Department of Health and Social Care
Spinal Muscular Atrophy: Drugs
Commons
To ask the Secretary of State for Health and Social Care, for what reason the announcement by NICE on 15 May 2019 that it would facilitate access by people with spinal muscular atrophy to a new drug for prescription on the NHS was followed several weeks later by an announcement that the drug would be available only to a specific group of those people; and if he will make a statement.
A
Answered by: Seema Kennedy
Answered on: 01 July 2019

The National Institute for Health and Care Excellence (NICE) has advised that on 15 May 2019 it confirmed that it was able to recommend nusinersen for the treatment of spinal muscular atrophy. In the announcement, NICE said the treatment would be made available under the terms of the managed access agreement between NHS England and NHS Improvement and Biogen. However, the full detail of the agreement was not given in the announcement and NICE accepts this was misleading for some of the patient population. NICE provided clarification at the earliest opportunity and has apologised to individuals affected.

Q
(Christchurch)
[N]
Close

Named Day

'Named day' questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.

Asked on: 26 June 2019
Department for Work and Pensions
Pension Credit
Commons
To ask the Secretary of State for Work and Pensions, what processes he has in place to enable relatives with lasting power of attorney registered with the Public Guardian to apply for pension credit on behalf of those for whom they are responsible; and if he will make a statement.
A
Answered by: Guy Opperman
Answered on: 01 July 2019

The Department for Work and Pensions has processes in place to ensure that someone with a Power of Attorney can make a claim for Pension Credit on behalf of those for whom they are responsible. The Department’s guidance on this is available online.

In order to confirm that an individual has the authority to act on behalf of the claimant, we ask to see the relevant Power of Attorney document and may need to verify authenticity with the Office of the Public Guardian or Office of the Public Guardian (Scotland). The original document can be taken into one of the Department’s offices or sent to the Department; a copy, authenticated by the claimant or donor, a lawyer or a stockbroker as a ‘true copy’, is equally acceptable.

Subject to confirmation that an individual has the authority to act on behalf of the claimant, the simplest method of making a claim is by telephone, which removes the need for claimants and their representatives to complete lengthy application forms. However, paper forms are also available for those who prefer and can be completed with the assistance of a DWP visiting officer if required.

Expand all answers
Print selected
Showing 1-20 out of 67
Results per page
Results per page 20 | 50 | 100